TURTLE CAMERON

PrivateCIK: 1758363
Location

WALTHAM, MA

TURTLE CAMERON (Chief Executive Officer) sold 2.7% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market

Open‑market sale worth $1.38M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 6 sales
InsiderTURTLE CAMERONCIK 1758363
→
IssuerSPYRE THERAPEUTICS, INC.CIK 1636282
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$1.38M
Total sold
6
Open market trades
0B · 6S
6
Total transactions
15K disposed
Non-Derivative Transactions6

Common Stock

Direct
S · Sale

Shares

−600.00

Price / share

$89.14

Trade value

$53.48K

% of position

0.1%
10/1/2026
552.54K→551.94K

Common Stock

Direct
S · Sale

Shares

−2.68K

Price / share

$90.10

Trade value

$241.74K

% of position

0.5%
10/1/2026
551.94K→549.26K

Common Stock

Direct
S · Sale

Shares

−2.64K

Price / share

$91.49

Trade value

$241.35K

% of position

0.5%
10/1/2026
549.26K→546.62K

Common Stock

Direct
S · Sale

Shares

−3.99K

Price / share

$92.31

Trade value

$368.22K

% of position

0.7%
10/1/2026
546.62K→542.63K

Common Stock

Direct
S · Sale

Shares

−4.99K

Price / share

$93.37

Trade value

$465.92K

% of position

0.9%
10/1/2026
542.63K→537.64K

Common Stock

Direct
S · Sale

Shares

−100.00

Price / share

$93.91

Trade value

$9.39K

% of position

0.0%
10/1/2026
537.64K→537.54K
Total

Net shares

−15K

Net value

-$1.38M

Derivative Transactions0
No derivative transactions reported
TURTLE CAMERON — Insider Transaction (Form 4) Filed Oct 3, 2026 | Finecho